Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)

被引：0
|
作者：
Harindhanavudhi, Tasma
Freese, Rebecca L.
Caramori, Luiza
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-396-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
396-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D)
    Chu, Lisa
    Bhogal, Sanjit K.
    Lin, Peter
    Steele, Andrew
    Fuller, Mark
    Ciaccia, Antonio
    Abitbol, Alexander
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (05) : 464 - 472
  • [2] Physicians' Chronic Kidney Disease (CKD) Awareness over Time in Type 2 Diabetes (T2D)
    Schempf, John
    Freese, Rebecca L.
    Caramori, Luiza
    Harindhanavudhi, Tasma
    [J]. DIABETES, 2020, 69
  • [3] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [4] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [5] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [6] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [7] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [8] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S116 - S116
  • [9] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [10] A Prediction Model on Incident End-Stage Kidney Disease (ESKD) among Individuals with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    [J]. DIABETES, 2022, 71
12345